191 – 200 of 661
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany
- Contribution to journal › Article
-
Mark
Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics
- Contribution to journal › Article
-
Mark
Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR
- Contribution to journal › Article
-
Mark
Venous thromboembolism and cancer risk
- Contribution to journal › Article
-
Mark
Thrombin generation assays (TGAs)
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Preference-based valuation of treatment attributes in haemophilia A using web survey
- Contribution to journal › Article
-
Mark
Cohort-specific imputation of gene expression improves prediction of warfarin dose for African Americans
- Contribution to journal › Article
-
Mark
Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients : Results of the INSIGHT case-control study
- Contribution to journal › Article
-
Mark
At the Cross Section of Thrombotic Microangiopathy and Atypical Hemolytic Uremic Syndrome : A Narrative Review of Differential Diagnostics and a Problematization of Nomenclature
- Contribution to journal › Scientific review
-
Mark
If you know you will also see : Population pharmacokinetics is the way to personalize and optimize prophylaxis in hemophilia
- Contribution to journal › Debate/Note/Editorial
